This study demonstrated that ZWD can ameliorate proteinuria, pathological damage, and fibrosis in renal tissue, and reduce water retention by downregulating the AVP-VR2-AQP2 and RAAS-MR-AQP3 pathways to intervene in ADR-induced NS in rats. The gene discussed is VTRNA1-2; the disease is Netherton syndrome.